Double blind, randomized, placebo-controlled study of dexamethasone therapy for hematogenous septic arthritis in children

Abstract

A short course of dexamethasone reduced residual joint dysfunction and shortened significantly the duration of symptoms in children with documented hematogenous septic arthritis. These results suggest that a 4-day course of low dose dexamethasone given early benefits children with hematogenous septic arthritis.